1Schwabe RF, Jobin C. The microbiome and cancer. Nat RevCancer 2013; 13: 800-812 [PMID: 24132111 DOI: 10.1038/nrc3610].
2Dickson RP, Martinez FJ, Huffnagle GB. The role of themicrobiome in exacerbations of chronic lung diseases.Lancet 2014; 384: 691-702 [PMID: 25152271 DOI: 10.1016/S0140-6736(14)61136-3].
3Kahn SE, Cooper ME, Del Prato S. Pathophysiology andtreatment of type 2 diabetes: perspectives on the past, present,and future. Lancet 2014; 383: 1068-1083 [PMID: 24315620 DOI:10.1016/S0140-6736(13)62154-6].
4Ogino S, Galon J, Fuchs CS, Dranoff G. Cancer immunology--analysis of host and tumor factors for personalized medicine. NatRev Clin Oncol 2011; 8: 711-719 [PMID: 21826083 DOI: 10.1038/nrclinonc.2011.122].
5Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driverpassengermodel for colorectal cancer: beyond the usual suspects.Nat Rev Microbiol 2012; 10: 575-582 [PMID: 22728587 DOI:10.1038/nrmicro2819].
6Signat B, Roques C, Poulet P, Duffaut D. Fusobacteriumnucleatum in periodontal health and disease. Curr Issues Mol Biol2011; 13: 25-36 [PMID: 21220789].
7Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, GroteVA, Tjneland A, Dahm CC, Overvad K, Jenab M, Fedirko V,Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Kaaks R,Boeing H, Foerster J, Trichopoulou A, Lagiou P, Trichopoulos D,Sacerdote C, Sieri S, Palli D, Tumino R, Panico S, Siersema PD,Peeters PH, Lund E, Barricarte A, Huerta JM, Molina-Montes E,Dorronsoro M, Quir JR, Duell EJ, Ye W, Sund M, Lindkvist B,Johansen D, Khaw KT, Wareham N, Travis RC, Vineis P, Buenode-Mesquita HB, Riboli E. Plasma antibodies to oral bacteria andrisk of pancreatic cancer in a large European prospective cohortstudy. Gut 2013; 62: 1764-1770 [PMID: 22990306 DOI: 10.1136/gutjnl-2012-303006].
8Michaud DS. Role of bacterial infections in pancreatic cancer.Carcinogenesis 2013; 34: 2193-2197 [PMID: 23843038 DOI:10.1093/carcin/bgt249].
9Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N.Induction of experimental ulcerative colitis by Fusobacteriumvarium isolated from colonic mucosa of patients with ulcerativecolitis. Gut 2003; 52: 79-83 [PMID: 12477765].
10Minami M, Ando T, Okamoto A, Sasaki N, Ohkura T, Torii K,Hasegawa T, Ohta M, Goto H. Seroprevalence of Fusobacteriumvarium in ulcerative colitis patients in Japan. FEMS Immunol MedMicrobiol 2009; 56: 67-72 [PMID: 19484811].
